Loading…
avatar for Helen Edelberg

Helen Edelberg

Bristol-Myers Squibb
Head of Medical Safety Assessment, Innovative Medicines & Global Safety Risk Mgt
Dr Helen Edelberg is Head of Med Safety Assmt for Innovative Med & Gbl Safety Risk Mgmt, which provides authoritative expertise on development & execution of rigorous & innovative risk mgmt strategies at BMS. A strategic & innovative biopharmaceutical exec & physician with ~20 years Reg/PV & academic med/clin practice experience, she has presented on devt & implementation of best practices to accelerate product devt, approval & ongoing benefit-risk evaluation in a variety of settings.

My Speakers Sessions

Tuesday, June 26
 

2:00pm